Both of the S1P-catabolizing genes, SGPP1 and PLPP3, showed high predictive value for response to systematic therapy in invasive breast carcinoma patients and especially in the HER2+ and basal subtypes (Table 4). The gene discussed is MBTPS1; the disease is invasive breast carcinoma.